Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate

Drug Delivery and Translational Research

Volumn 1, Issue 4, 2011, Pages 309-321

  Jain, Sanyog ^a   Chaudhari, Bankim H ^a   Swarnakar, Nitin K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Iontophoresis; Isosorbide dinitrate; Niosomal gel; Niosomes; Transdermal delivery

Indexed keywords

CARBOMER; CARBOPOL 974P; CHOLESTEROL; ISOSORBIDE DINITRATE; NIOSOME; PROPYLENE GLYCOL; SEPHADEX; SORBITAN OLEATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DENSITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; ENCAPSULATION; FILM; FLOW KINETICS; GEL; HAIR FOLLICLE; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; MALE; NONHUMAN; PARTICLE SIZE; PASSIVE TRANSPORT; POROSITY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; THIXOTROPY; ZETA POTENTIAL;

EID: 84862996439     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-011-0035-1     Document Type: Article

References (52)

1. Barry BW. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker; 1983.
2. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004; 56: 619-58.
3. Beastall JC, Hadgraft J, Washington C. Mechanism of action of azone as a percutaneous penetration enhancer: lipid bilayer fluidity and transition temperature effects. Int J Pharm. 1988; 43(3): 207-13.
4. Curdy C, kalia YN, Naik A, Guy RH. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Contr Rel. 2001; 76: 73-9.
5. Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev. 2004; 56(5): 589-601. doi: 10. 1016/j. addr. 2003. 10. 024.
6. Patel SR, Zhong H, Sharma A, Kalia YN. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Eur J Pharm Biopharm. 2009; 72(2): 304-9.
7. Rizwan M, Aqil M, Talegaonkar S, Azeem A, Sultana Y, Ali A. Enhanced transdermal drug delivery techniques: an extensive review of patents. Recent Pat Drug Deliv Formul. 2009; 3(2): 105-24.
8. Vutla NB, Betageri GV, Banga AK. Transdermal iontophoretic delivery of enkephalin formulated in liposomes. JPharm Sci. 1996; 85(1): 5-8.
9. Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998; 1368(2): 201-15.
10. Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel. 1994; 30(1): 1-15.
11. Rhee YS, Choi JG, Park ES, Chi SC. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm. 2001; 228(1-2): 161-70.
12. Lee PW, Peng SF, Su CJ, Mi FL, Chen HL, Wei MC, et al. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials. 2008; 29(6): 742-51.
13. Liu W, Hu M, Liu W, Xue C, Xu H, Yang X. Investigation of carbopol gel of solid lipid nanoparticle for the transdermal iontophoretic delivery of triamcinolone acetoinde acetate. Int J Pharm. 2008; 364: 135-41.
14. Kulkarni SB, Banga AK, Betageri GV. Transdermal lontophoretic delivery of colchicine encapsulated in liposomes. Drug Deliv. 1996; 3(4): 245-50.
15. Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Rel. 1998; 54: 149-65.
16. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm. 2001; 219(1-2): 61-72.
17. Vyas SP, Singh RP, Jain S, Mishra V, Mahor S, Singh P, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm. 2005; 296(1-2): 80-6.
18. El Maghraby GMM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm. 2000; 204(1-2): 159-69.
19. Available from: http://www. drugbank. ca/drugs/DB00883. Accessed 18 March 2010.
20. Gabiga H, Cal K, Janicki S. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Int J Pharm. 2000; 199(1): 1-6.
21. Zhao L, Fang L, Xu Y, Liu S, He Z, Zhao Y. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers. Eur J Pharm Biopharm. 2008; 69(1): 199-213.
22. Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev. 2001; 50(3): 175-203.
23. Riviere JE, Brooks JD, Williams PL, McGown E, Francoeur ML. Cutaneous metabolism of isosorbide dinitrate after transdermal administration in isolated perfused porcine skin. Int J Pharm. 1996; 127(2): 213-7.
24. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 2001; 228(1-2): 43-52.
25. Guideline I. Validation of analytical procedures: text and methodology Q2 (R1). Geneva: IFPMA; 2005.
26. Nair VB, Panchagnula R. The effect of pretreatment with terpenes on transdermal iontophoretic delivery of arginine vasopressin. Il Farmaco. 2004; 59(7): 575-81.
27. Panchagnula R, Patel JR. Transdermal delivery of azidothymidine (AZT) through rat skin ex vivo. Pharm Pharmacol Comm. 1997; 3: 83-7.
28. Panchagnula R, Bokalial R, Sharma P, Khandavilli S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm. 2005; 293(1-2): 213-23.
29. Bommannan DB, Tamada J, Leung L, Potts RO. Effect of electroporation on transdermal lontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm Res. 1994; 11(12): 1809-14.
30. Nair VB, Panchagnula R. Influence of electrical parameter in the iontophoretic delivery of small peptide: in vitro studies using arginine-vasopressin as a model peptide. Il Farmaco. 2004; 59: 583-93.
31. Dingler A. Freie Universität B. Feste Lipid-nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation. Freie Universität Berlin; 1998.
32. Kanikkannan N, Singh J, Ramarao P. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J Control Release. 1999; 59(1): 99-105.
33. Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies. Eur J Pharm Sci. 2010; 39(5): 387-93.
34. De Gier J, Mandersloot JG, van Deenen LLM. Lipid composition and permeability of liposomes. Biochim Biophys Acta. 1968; 150(4): 666-75.
35. Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. Pharmaceutical press; 2006.
36. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008; 361(1-2): 104-11.
37. El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006; 308(1-2): 140-8.
38. Arica B, Ozer AY, Ercan MT, Hincal AA. Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. J Microencapsul. 1995; 12(5): 469-85. doi: 10. 3109/02652049509006778.
39. Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm. 2002; 242(1-2): 381-4.
40. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005; 306(1-2): 71-82. doi: 10. 1016/j. ijpharm. 2005. 09. 023.
41. Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux JC. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm. 2000; 203(1-2): 89-98.
42. Lippacher A, Müller RH, Mäder K. Liquid and semisolid SLN (TM) dispersions for topical application: rheological characterization. Eur J Pharm Biopharm. 2004; 58(3): 561-7.
43. Islam MT, Rodriguez-Hornedo N, Ciotti S, Ackermann C. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res. 2004; 21(7): 1192-9.
44. Lelawongs P, Liu JC, Chien YW. Transdermal iontophoretic delivery of arginine-vasopressien (II). Evaluation of electrical and operational factors. Int J Pharm. 1990; 61: 179-88.
45. Valjakka-Koskela R, Kirjavainen M, Mönkkönen J, Urtti A, Kiesvaara J. Enhancement of percutaneous absorption of naproxen by phospholipids. Int J Pharm. 1998; 175(2): 225-30.
46. Jain S, Vyas SP. Mannosylated niosomes as carrier adjuvant system for topical immunization. JPharm Pharmacol. 2005; 57(9): 1177-84.
47. Sims SM, Higuchi WI, Srinivasan V. Skin alteration in convective solvent flow effects during iontophoresis. I. Neutral solutes transport across human skin. Int J Pharm. 1991; 69: 109-21.
48. Kasting GB, Bowman LA. DC electrical properties of frozen, excised human skin. Pharm Res. 1990; 7(2): 134-43.
49. Oh SY, Leung L, Bommannan D, Guy RH, Potts RO. Effect of current, ionic strength and temperature on the electrical properties of skin. J Control Rel. 1993; 27(2): 115-25.
50. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci. 1993; 90(22): 10504.
51. Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Delivery Rev. 2007; 59(11): 1152-61.
52. Escobar-Chavez JJ, Merino-Sanjuán V, López-Cervantes M, Urban-Morlan Z, Piñón-Segundo E, Quintanar-Guerrero D, et al. The tape-stripping technique as a method for drug quantification in skin. J Pharm Pharma Sci. 2008; 11(1): 104.